New medicines are approved. Biosimilars launch. Payers revise policies. HCPCS codes change. Assistance programs open, close or move. MedicineCostHelp is designed as a maintained resource—not a one-time database dump.
The action plan now adds state-aware Medicaid routing, patient/care-team modes, questions to ask and a copyable/printable handoff. Care teams also get a public QR handout and copyable patient introduction.
Build a plan → · Share toolkit →Primary IgA nephropathy · weekly SC biologic.
Open guide →Chronic hepatitis delta · SC specialty therapy.
Open guide →Achondroplasia · once-weekly SC injection.
Open guide →Aetna revised CPB 0804 on August 21. MedicineCostHelp flagged the change for human review; the denosumab guidance was then updated to reflect Ponlimsi's addition to the Prolia biosimilar pathway and Aetna's new site-of-care language. Public guidance was not rewritten automatically.
Open the denosumab coverage family →FDA-approved July 24, 2026 for neovascular (wet) age-related macular degeneration. We added a new-to-market coverage guide that does not pretend payer preference or permanent coding has already caught up.
Lytenava coverage guide →The first FDA-approved interchangeable IV biosimilar to Simponi Aria. Its current FDA indication is narrower than the reference product, so our engine now supports product-specific indication filtering.
Immgolis Intri coverage guide →Added the July 31 FDA expansion into PSMA-positive metastatic androgen pathway modulation-naïve/sensitive prostate cancer in combination with ARPI therapy.
Pluvicto coverage guide →Added the 2026 Stage 2 age expansion and the new pediatric Stage 3 type 1 diabetes indication so the coverage navigator no longer assumes the older label.
Tzield coverage guide →Updated the gene-therapy pathway after FDA expanded sickle cell disease and transfusion-dependent beta-thalassemia use to eligible patients age 2 years and older.
Casgevy coverage guide →A changed fingerprint is a reason to review a source—not permission for software to reinterpret an insurance policy. Consequential coverage, coding and patient-guidance changes require human review before the public site changes.
Send us the page, what looks wrong, and the current official source if you have it. Do not send patient information.
Contact & corrections →Machine-readable: updates-data.json · RSS feed